 "Markets likely to open flat; steel stocks in focus")
Markets are likely to open flat with negative bias after Asian shares pared early gains and were trading with losses. Meanwhile, steel stocks will be in focus after the sharp rally in Chinese steel prices.
At 8:25am, the early indicator SGX Nifty was down 18 points at 7,493.
Foreign Institutional investors were net buyers in equities to the tune of Rs 672 crore on Friday, as per provisional stock exchange data.
Asian shares which had opened higher tracking firm global crude oil and commodity prices witnessed profit taking to pare early gains and were trading in negative terrain. Shares in China were the top losers in the region with Shanghai Composite down 2.7% while Japan's Nikkei eased 1.7%. Hong Kong's Hang Seng fell 1% and Singapore's Straits Times was down 0.6%.
US stocks ended higher on Monday with energy shares leading the gains after crude oil prices firmed up while technology shares ended with losses. The Dow Jones industrial average ended up 0.4% at 17,074, the S&P 500 rose 0.1% at 2,002 and the Nasdaq ended down 0.2% at 4,708.
STOCKS TO WATCH
Steel stocks are likely to be in focus after sharp rally in China steel prices on Monday.
Oil exploration stocks such as ONGC and Cairn India are likely to firm tracking a rally in global crude oil prices.
Tata Motors will be in focus after it signed an agreement with Bharat Forge and General Dynamics Land Systems (GDLS) of the US, for the ministry of defence's (MoD’s) Future Infantry Combat Vehicle (FICV) programme.
Coal India is likely to firm after the board approved payment of interim dividend of Rs 27.40 per equity share for the financial year 2015-16.
Ajanta Pharma is likely to firm up after the company said it has received US FDA Approval for Almotriptan Malate Tablets.
Mindtree is likely to remain muted after the company said that in dollar terms it is expected to report marginal Quarter-on-Quarter revenue growth for fourth quarter on an organic basis mainly due to delay in commencement of few projects in retail and consumer packaged goods and BFSI vertical.
Strides Shasun may firm up after the company plans to acquire 3 brands of Moberg Pharma for US $10 million.
Alkem Labs may firm up after the company said that it's Mandva Plant has successfully obtained the Establishment Inspection Report from the US FDA.
At 8:25am, the early indicator SGX Nifty was down 18 points at 7,493.
Foreign Institutional investors were net buyers in equities to the tune of Rs 672 crore on Friday, as per provisional stock exchange data.
More From This Section
GLOBAL MARKETS
Asian shares which had opened higher tracking firm global crude oil and commodity prices witnessed profit taking to pare early gains and were trading in negative terrain. Shares in China were the top losers in the region with Shanghai Composite down 2.7% while Japan's Nikkei eased 1.7%. Hong Kong's Hang Seng fell 1% and Singapore's Straits Times was down 0.6%.
US stocks ended higher on Monday with energy shares leading the gains after crude oil prices firmed up while technology shares ended with losses. The Dow Jones industrial average ended up 0.4% at 17,074, the S&P 500 rose 0.1% at 2,002 and the Nasdaq ended down 0.2% at 4,708.
STOCKS TO WATCH
Steel stocks are likely to be in focus after sharp rally in China steel prices on Monday.
Oil exploration stocks such as ONGC and Cairn India are likely to firm tracking a rally in global crude oil prices.
Tata Motors will be in focus after it signed an agreement with Bharat Forge and General Dynamics Land Systems (GDLS) of the US, for the ministry of defence's (MoD’s) Future Infantry Combat Vehicle (FICV) programme.
Coal India is likely to firm after the board approved payment of interim dividend of Rs 27.40 per equity share for the financial year 2015-16.
Ajanta Pharma is likely to firm up after the company said it has received US FDA Approval for Almotriptan Malate Tablets.
Mindtree is likely to remain muted after the company said that in dollar terms it is expected to report marginal Quarter-on-Quarter revenue growth for fourth quarter on an organic basis mainly due to delay in commencement of few projects in retail and consumer packaged goods and BFSI vertical.
Strides Shasun may firm up after the company plans to acquire 3 brands of Moberg Pharma for US $10 million.
Alkem Labs may firm up after the company said that it's Mandva Plant has successfully obtained the Establishment Inspection Report from the US FDA.